Stephen R. Allen - Net Worth and Insider Trading

Stephen R. Allen Net Worth

The estimated net worth of Stephen R. Allen is at least $54,250 dollars as of 2025-03-22. Stephen R. Allen is the Director of Niagen Bioscience Inc and owns about 7,000 shares of Niagen Bioscience Inc (NAGE) stock worth over $54,250. Details can be seen in Stephen R. Allen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen R. Allen has not made any transactions after 2017-08-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Stephen R. Allen

To

Stephen R. Allen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen R. Allen owns 1 companies in total, including Niagen Bioscience Inc (NAGE) .

Click here to see the complete history of Stephen R. Allen’s form 4 insider trades.

Insider Ownership Summary of Stephen R. Allen

Ticker Comapny Transaction Date Type of Owner
NAGE Niagen Bioscience Inc 2017-08-25 director

Stephen R. Allen Latest Holdings Summary

Stephen R. Allen currently owns a total of 1 stock. Stephen R. Allen owns 7,000 shares of Niagen Bioscience Inc (NAGE) as of August 25, 2017, with a value of $54,250.

Latest Holdings of Stephen R. Allen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NAGE Niagen Bioscience Inc 2017-08-25 7,000 7.75 54,250

Holding Weightings of Stephen R. Allen


Stephen R. Allen Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen R. Allen has made a total of 0 transactions in Niagen Bioscience Inc (NAGE) over the past 5 years. The most-recent trade in Niagen Bioscience Inc is the acquisition of 2,000 shares on August 25, 2017, which cost Stephen R. Allen around $6,620.

Insider Trading History of Stephen R. Allen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen R. Allen Trading Performance

GuruFocus tracks the stock performance after each of Stephen R. Allen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen R. Allen is 45.88%. GuruFocus also compares Stephen R. Allen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen R. Allen within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Stephen R. Allen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Stephen R. Allen

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.99 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 7.51 LIMIT LIMIT LIMIT LIMIT LIMIT

Stephen R. Allen Ownership Network

Ownership Network List of Stephen R. Allen

No Data

Ownership Network Relation of Stephen R. Allen

Insider Network Chart

Stephen R. Allen Owned Company Details

What does Niagen Bioscience Inc do?

Who are the key executives at Niagen Bioscience Inc?

Stephen R. Allen is the director of Niagen Bioscience Inc. Other key executives at Niagen Bioscience Inc include director & 10 percent owner & Chief Executive Officer Jaksch Frank L Jr , SVP Finance / Interim CFO Brianna Gerber , and 10 percent owner Champion River Ventures Ltd .

Niagen Bioscience Inc (NAGE) Insider Trades Summary

Over the past 18 months, Stephen R. Allen made no insider transaction in Niagen Bioscience Inc (NAGE). Other recent insider transactions involving Niagen Bioscience Inc (NAGE) include a net sale of 37,161 shares made by Jaksch Frank L Jr , a net sale of 23,000 shares made by Kristin Patrick , and a net purchase of 5,000 shares made by Brianna Gerber .

In summary, during the past 3 months, insiders sold 0 shares of Niagen Bioscience Inc (NAGE) in total and bought 273 shares, with a net purchase of 273 shares. During the past 18 months, 60,161 shares of Niagen Bioscience Inc (NAGE) were sold and 8,180 shares were bought by its insiders, resulting in a net sale of 51,981 shares.

Niagen Bioscience Inc (NAGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Niagen Bioscience Inc Insider Transactions

No Available Data

Stephen R. Allen Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen R. Allen. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Stephen R. Allen's mailing address is: Pasadena Ca 91101.